220 related articles for article (PubMed ID: 32619957)
1. Development of an immune gene prognostic classifier for survival prediction and respond to immunocheckpoint inhibitor therapy/chemotherapy in endometrial cancer.
Liu J; Chen X; Jiang Y; Cheng W
Int Immunopharmacol; 2020 Sep; 86():106735. PubMed ID: 32619957
[TBL] [Abstract][Full Text] [Related]
2. Protein-based prognostic signature for predicting the survival and immunotherapeutic efficiency of endometrial carcinoma.
Lai J; Xu T; Yang H
BMC Cancer; 2022 Mar; 22(1):325. PubMed ID: 35337291
[TBL] [Abstract][Full Text] [Related]
3. Development of a prognostic signature for esophageal cancer based on nine immune related genes.
Zhang Z; Chen C; Fang Y; Li S; Wang X; Sun L; Zhou G; Ye J
BMC Cancer; 2021 Feb; 21(1):113. PubMed ID: 33541291
[TBL] [Abstract][Full Text] [Related]
4. Establishing a Prognostic Signature Based on Epithelial-Mesenchymal Transition-Related Genes for Endometrial Cancer Patients.
Liu J; Cui G; Shen S; Gao F; Zhu H; Xu Y
Front Immunol; 2021; 12():805883. PubMed ID: 35095892
[TBL] [Abstract][Full Text] [Related]
5. Follicular Helper T-Cell-Based Classification of Endometrial Cancer Promotes Precise Checkpoint Immunotherapy and Provides Prognostic Stratification.
Chen Y; You S; Li J; Zhang Y; Kokaraki G; Epstein E; Carlson J; Huang WK; Haglund F
Front Immunol; 2021; 12():788959. PubMed ID: 35069566
[TBL] [Abstract][Full Text] [Related]
6. An immune-related prognostic signature for thyroid carcinoma to predict survival and response to immune checkpoint inhibitors.
Wu P; Sun W; Zhang H
Cancer Immunol Immunother; 2022 Mar; 71(3):747-759. PubMed ID: 34398303
[TBL] [Abstract][Full Text] [Related]
7. Construction of an immune-related gene signature for prediction of prognosis in patients with cervical cancer.
Mei J; Xing Y; Lv J; Gu D; Pan J; Zhang Y; Liu J
Int Immunopharmacol; 2020 Nov; 88():106882. PubMed ID: 32799114
[TBL] [Abstract][Full Text] [Related]
8. Identification of an immune checkpoint gene signature that accurately predicts prognosis and immunotherapy response in endometrial carcinoma.
Li S; Dong C; Chen J; Gao X; Xie X; Zhang X
Aging (Albany NY); 2021 Jun; 13(12):16696-16712. PubMed ID: 34158412
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of S100P predicts the poor long-term survival and construction of prognostic signature for survival and immunotherapy in patients with pancreatic cancer.
Zou W; Li L; Wang Z; Jiang N; Wang F; Hu M; Liu R
Bioengineered; 2021 Dec; 12(1):9006-9020. PubMed ID: 34654352
[TBL] [Abstract][Full Text] [Related]
10. Identification and Validation of Immune-Related Gene for Predicting Prognosis and Therapeutic Response in Ovarian Cancer.
Zhang ZC; Guo JN; Zhang N; Wang ZQ; Lou G; Cui BB; Yang C
Front Immunol; 2021; 12():763791. PubMed ID: 34880862
[TBL] [Abstract][Full Text] [Related]
11. Identification and validation of an immune prognostic signature in colorectal cancer.
Li M; Wang H; Li W; Peng Y; Xu F; Shang J; Dong S; Bu L; Wang H; Wei W; Hu Q; Liu L; Zhao Q
Int Immunopharmacol; 2020 Nov; 88():106868. PubMed ID: 32771948
[TBL] [Abstract][Full Text] [Related]
12. A novel immune-related gene signature for diagnosis and potential immunotherapy of microsatellite stable endometrial carcinoma.
Xiao Y; Yu X; Wang Y; Song G; Liu M; Wang D; Wang H
Sci Rep; 2024 Feb; 14(1):3738. PubMed ID: 38355782
[TBL] [Abstract][Full Text] [Related]
13. Identification of a prognostic immune signature for cervical cancer to predict survival and response to immune checkpoint inhibitors.
Yang S; Wu Y; Deng Y; Zhou L; Yang P; Zheng Y; Zhang D; Zhai Z; Li N; Hao Q; Song D; Kang H; Dai Z
Oncoimmunology; 2019; 8(12):e1659094. PubMed ID: 31741756
[TBL] [Abstract][Full Text] [Related]
14. Integrated analysis of tumor mutation burden and immune infiltrates in endometrial cancer.
Zhou H; Chen L; Lei Y; Li T; Li H; Cheng X
Curr Probl Cancer; 2021 Apr; 45(2):100660. PubMed ID: 33012523
[TBL] [Abstract][Full Text] [Related]
15. Development and Validation of a Five-immune Gene Pair Signature in Endometrial Carcinoma.
Li N; Yu K; Lin Z; Zeng D
Comb Chem High Throughput Screen; 2021; 24(2):233-245. PubMed ID: 32729416
[TBL] [Abstract][Full Text] [Related]
16. The role of an immune signature for prognosis and immunotherapy response in endometrial cancer.
Meng Y; Yang Y; Zhang Y; Yang X; Li X; Hu C
Am J Transl Res; 2021; 13(2):532-548. PubMed ID: 33594308
[TBL] [Abstract][Full Text] [Related]
17. Identification of a prognostic signature of epithelial ovarian cancer based on tumor immune microenvironment exploration.
Liu J; Meng H; Nie S; Sun Y; Jiang P; Li S; Yang J; Sun R; Cheng W
Genomics; 2020 Nov; 112(6):4827-4841. PubMed ID: 32890701
[TBL] [Abstract][Full Text] [Related]
18. Exploration of a novel prognostic risk signatures and immune checkpoint molecules in endometrial carcinoma microenvironment.
Liu J; Nie S; Wu Z; Jiang Y; Wan Y; Li S; Meng H; Zhou S; Cheng W
Genomics; 2020 Sep; 112(5):3117-3134. PubMed ID: 32474122
[TBL] [Abstract][Full Text] [Related]
19. Immune-related gene-based prognostic index for predicting survival and immunotherapy outcomes in colorectal carcinoma.
Liang Z; Sun R; Tu P; Liang Y; Liang L; Liu F; Bian Y; Yin G; Zhao F; Jiang M; Gu J; Tang D
Front Immunol; 2022; 13():944286. PubMed ID: 36591255
[TBL] [Abstract][Full Text] [Related]
20. Identification of prognostic immune-related genes in the tumor microenvironment of endometrial cancer.
Chen P; Yang Y; Zhang Y; Jiang S; Li X; Wan J
Aging (Albany NY); 2020 Feb; 12(4):3371-3387. PubMed ID: 32074080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]